NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

SLIMMING pills made by leading companies behind the fat jabs have been put in a head-to-head trial. Orforglipron led to almost double the weight loss than semaglutide and was better at controlling ...

The new NICE guidance recommends that most people should now be offered metformin along with an SGLT-2 inhibitor from the start, while also advising that they get a slow-release formulation of ...

Read more about why patients with type 2 diabetes will now be offered SGLT-2 inhibitors much earlier in the treatment process.

New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes ...

People who ranked highly on scores associated with metabolic syndrome and reduced beta-cell function had a substantially higher risk of developing both type 2 diabetes and high blood pressure. The key ...

An upcoming recommendation by NICE to use SGLT-2 inhibitors more routinely in type 2 diabetes could save many thousands of lives a year.

A new daily weight loss pill can help patients with type 2 diabetes lose more weight and better control their blood sugar ...